If youre bullish on oil, then Continental Resources (CLR) is the stock for you. I believe the company will likely significantly grow its earnings in 2018 due to higher realized prices and around 20% production growth. Meanwhile the company, which burned cash flows in 2017, will likely report str
New homebuyers have a number of things to consider before taking on a 3% down-payment mortgage loan, from nailing down how much house they can afford to choosing the right mortgage lender and thensecuring a low mortgage rateonce approved.
In the video segment below, The Motley Fool analysts Nathan Hamilton and Kristine Harjes talk about 3% down-payment mortgages and discuss a few important....More>>>
Did you see it happen? Have you noticed the most important trend in finance this year? Most folks haven't. They have no idea what's going on… They completely missed this enormous shift. They have no idea that for the first time in years, the U.S. dollar is crashing. This is an enormous change from the past few years. And history tells us that the losses....More>>>
Death and finances are two of the most difficult topics for people to talk about, and when you put them together, you have a conversation that a lot of people avoid at all costs. Yet the fact of the matter is people are living longer. This means you will have more medical expenses and may be taking care of a loved one with a chronic illness for a long time. Additionally,....More>>>
In a week that offered up almost everything, and was completed by another outstanding nonfarm payroll report, the insider activity that had been heavily leaning toward the sellers started to balance out. While the insiders selling shares still came in higher than the buyers, for one of the first times in 2017 it seemed to balance out some. One thing is for sure, if the market continues higher, the....More>>>
Money Morning Director of Technology & Venture Capital Research Michael Robinson is still a big fan of Bitcoin and many of the other cryptocurrencies out there. But he acknowledges that they are not for everyone.
Shares of Kura Oncology (KURA) have risen by more than 90% since I presented the idea to readers in September of last year. The stock has climbed 38% since my update piece published in late November in which I stated my expectations of continued upside due to multiple clinical catalysts in 2018